PC
HZNP

PointState Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

PointState Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25,000
Closed -$2.69M – 170
2021
Q4 		$2.69M Sell
25,000
-20,000
-44% -$2.18M 0.08% 102
2021
Q3 		$4.93M Sell
45,000
-10,000
-18% -$1.04M 0.12% 104
2021
Q2 		$5.15M Buy
+55,000
New +$5.06M 0.12% 93
2021
Q1 		– Sell
-26,250
Closed -$1.92M – 182
2020
Q4 		$1.92M Buy
+26,250
New +$1.95M 0.05% 112
2016
Q4 		– Sell
-100,000
Closed -$1.81M – 192
2016
Q3 		$1.81M Buy
+100,000
New +$1.95M 0.03% 132
2015
Q2 		– Sell
-250,000
Closed -$6.49M – 193
2015
Q1 		$6.49M Buy
+250,000
New +$4.58M 0.1% 91

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return